A comprehensive and multidimensional program, the event brought together several speakers:

  • Our president shared HTL’s vision and leadership for the future,
  • Anne-Laure Gaudry, Chief Innovation & Portfolio Strategy Officer, presented our portfolio of premium biopolymers,
  • Dr. Abs, medical expert and partner of HTL, demonstrated why the quality of our hyaluronic acid makes a difference in finished products.
  • Lixin DAI, Director of Research & Scientific Affairs, highlighted the potential of polynucleotides and recombinant collagen in aesthetic medicine.

Multiple objectives to support our growth in Asia:

  • Strengthen HTL’s leadership in premium biopolymers for aesthetic medicine.
  • Promote our comprehensive portfolio to Asian customers.
  • Generate engagement with key partners in China and Korea.
  • Educate the market on HTL’s scientific and industrial excellence.

The webinar was a resounding success, attracting an engaged audience and generating lots of positive feedback. Well done to all the teams involved—Marketing, Sales, and Innovation—for this exemplary international collaboration, which contributes to HTL’s reputation!

To see our most recent news,
follow us on LinkedIn

Go to our LinkedIn page